Company news

Neovasc Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Neovasc Shareholders Approve Acquisition by Shockwave Medical

March 6, 2023

Neovasc Announces German Reimbursement Renewal

February 1, 2023

Shockwave Medical to Acquire Neovasc

January 17, 2023

Neovasc Announces Progress on COSIRA-II Clinical Trial

November 28, 2022

Neovasc Comments on European Heart Journal Publication

November 18, 2022

Neovasc Announces Third Quarter Financial Results and Provides Corporate Update

November 10, 2022

Neovasc Reducer Obtains U.S. Outpatient Reimbursement

November 8, 2022

Neovasc to Report Third Quarter Financial Results on November 10, 2022

October 27, 2022

Neovasc Provides Corporate Update Following Clinical Data Release

September 20, 2022

Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit

September 16, 2022

Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina

September 15, 2022

Neovasc Announces Key Events at TCT 2022

September 8, 2022

Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference

August 30, 2022

Neovasc Announces Second Quarter Financial Results and Provides Corporate Update

August 11, 2022

Neovasc to Report Second Quarter Financial Results on August 11, 2022

July 28, 2022

Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations

July 26, 2022

Neovasc Announces Direct Sales Operations in United Kingdom

July 5, 2022

Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference

June 8, 2022

Neovasc to Participate in H.C. Wainwright Global Investment Conference

May 23, 2022

Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule

May 16, 2022

Neovasc Announces First Quarter Financial Results and Provides Corporate Update

May 12, 2022

Neovasc to Report First Quarter Financial Results on May 12, 2022

April 29, 2022

Neovasc Comments on European Heart Journal Publication

April 28, 2022

Neovasc Announces Effective Date of Share Consolidation

April 27, 2022

Neovasc to Participate in Bloom Burton & Co. Healthcare Investment Conference

April 20, 2022

Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders

April 13, 2022

Neovasc Announces Consolidation and Extension of Convertible Debt

March 24, 2022

Neovasc Announces Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update

March 10, 2022

Neovasc to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022

February 24, 2022

Neovasc Announces German Reimbursement Renewal and Commercial Progress

February 8, 2022

Independent Publication Reports Neovasc Reducer(TM) Demonstrates Cost Savings

February 4, 2022

Neovasc Announces Complete Dismissal of Securities Class Action Complaint with Prejudice

February 2, 2022

Neovasc Announces Publication Supporting the Neovasc Reducer(TM) Device

January 20, 2022

Neovasc Announces Case Series of First U.S. Reducer Implants Published in Peer-Reviewed Journal

January 18, 2022

Neovasc to Participate in H.C. Wainwright BIOCONNECT Virtual Conference

January 6, 2022

Neovasc Announces First Patient Enrollment in COSIRA-II Trial

January 5, 2022

Neovasc to Participate in Sidoti December Virtual Microcap Conference

December 1, 2021

Neovasc Reducer(TM) System Receives National Reimbursement in France

November 30, 2021

Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance

November 24, 2021

The National Institute for Health and Care Excellence of the United Kingdom Provides Positive Guidance for Neovasc Reducer System

November 24, 2021

Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update

November 9, 2021

Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021

November 1, 2021

Neovasc Reducer(TM) Featured in Polish Heart Journal

October 21, 2021

Neovasc REDUCER-I Study Published in EuroIntervention Journal

September 28, 2021

Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference

September 23, 2021

Neovasc Announces FDA Approval of COSIRA-II Clinical Trial

September 16, 2021

Neovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment Conference

August 30, 2021

Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA

August 17, 2021

Neovasc Announces Second Quarter 2021 Financial Results

August 10, 2021

Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021

July 27, 2021

Older news releases →

Decks

The 5 newest of 13 decks. Every deck is listed under its year.